42 posts
Standard
An unusually detailed examination of an Alzheimer’s patient’s brain has provided researchers with a rare and compelling glimpse into the biological mechanics of the disease. By comparing brain regions that responded to treatment against those that remained resistant, scientists have uncovered striking evidence that the removal of amyloid plaques—a hallmark of Alzheimer’s disease—may directly prevent…
Standard
An unusually detailed examination of a brain donated by a former Alzheimer’s disease clinical trial participant has provided scientists with what may be the most compelling evidence to date that clearing amyloid plaques can help protect the brain from the secondary, more destructive stages of the disease. The study, presented at the 2026 Alzheimer’s Association…
Standard
In a significant stride toward understanding the biological underpinnings of Alzheimer’s disease, researchers at Mount Sinai have uncovered critical new evidence regarding how APOE4—the most potent genetic risk factor for the condition—triggers progressive brain damage. Two landmark studies, published concurrently in the journals Cell and Cell Stem Cell, provide a transformative look at how this…
Standard
For decades, the scientific community’s understanding of Alzheimer’s disease and related tauopathies has been dominated by the study of what happens inside the brain. Researchers have spent years examining the buildup of toxic tau proteins and amyloid plaques, viewing the brain as an isolated environment where these pathologies wreak havoc. However, a groundbreaking study published…
Standard
In a significant breakthrough for neurodegenerative research, scientists at the Icahn School of Medicine at Mount Sinai have unveiled critical new insights into how APOE4—the most potent genetic risk factor for Alzheimer’s disease—actively contributes to brain damage. Through two high-impact studies published in the journals Cell and Cell Stem Cell, researchers have demonstrated that this…
Standard
For millions of older adults, the dual burden of cardiovascular health and neurodegenerative disease represents one of the most significant clinical challenges in modern geriatric medicine. Atrial fibrillation—a common heart rhythm disorder characterized by irregular and often rapid heartbeats—frequently coexists with Alzheimer’s disease, the most prevalent form of dementia. While clinicians have long relied on…
Standard
For millions of people worldwide, the APOE4 gene variant represents a significant shadow hanging over their long-term cognitive health. As the strongest known genetic risk factor for Alzheimer’s disease, APOE4 has long been a primary focus of neurological research. However, the exact mechanisms by which this genetic signature orchestrates the decline of brain function—and specifically,…
Standard
For decades, the prevailing consensus in neurology was that the devastating neurodegeneration seen in Alzheimer’s disease and related conditions was primarily an internal affair—a localized war occurring behind the formidable barricades of the blood-brain barrier. Scientists focused their efforts on the internal buildup of toxic proteins, such as amyloid plaques and tau tangles, viewing the…
Standard
Could the secret to detecting Alzheimer’s disease lie not in the complex diagnostic tests of a neurologist’s office, but in the quiet, often overlooked patterns of our nightly slumber? Researchers at the University of Liège (ULiège), with the vital support of the Stop Alzheimer’s Foundation, are currently exploring a compelling hypothesis: that subtle, seemingly innocuous…
Standard
For millions of older adults, the dual diagnosis of atrial fibrillation—a common heart rhythm disorder—and Alzheimer’s disease represents a complex medical challenge. Managing the cardiovascular risks of a chaotic heartbeat while simultaneously navigating the progressive neurodegeneration of dementia requires a delicate balance of care. Now, new research conducted by the Karolinska Institutet and published in…
